The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Olanzapine Versus Divalproex in the Treatment of Acute Mania
Abstract
OBJECTIVE: The effects of olanzapine and divalproex for the treatment of mania were compared in a large randomized clinical trial. METHOD: A 3-week, randomized, double-blind trial compared flexibly dosed olanzapine (5-20 mg/day) to divalproex (500-2500 mg/day in divided doses) for the treatment of patients hospitalized for acute bipolar manic or mixed episodes. The Young Mania Rating Scale and the Hamilton Depression Rating Scale were used to quantify manic and depressive symptoms, respectively. Safety was assessed with several measures. RESULTS: The protocol defined baseline-to-endpoint improvement in the mean total score on the Young Mania Rating Scale as the primary outcome variable. The mean Young Mania Rating Scale score decreased by 13.4 for patients treated with olanzapine (N=125) and 10.4 for those treated with divalproex (N=123). A priori categorizations defined response and remission rates: 54.4% of olanzapine-treated patients responded (> or = 50% reduction in Young Mania Rating Scale score), compared to 42.3% of divalproex-treated patients; 47.2% of olanzapine-treated patients had remission of mania symptoms (endpoint Young Mania Rating Scale < or = 12), compared to 34.1% of divalproex-treated patients. The decrease in Hamilton depression scale score was similar in the two treatment groups. Completion rates for the 3-week study were similar in both groups. The most common treatment-emergent adverse events (incidence >10%) occurring more frequently during treatment with olanzapine were dry mouth, increased appetite, and somnolence. For divalproex, nausea was more frequently observed. The average weight gain with olanzapine treatment was 2.5 kg, compared to 0.9 kg with divalproex treatment. CONCLUSIONS: The olanzapine treatment group had significantly greater mean improvement of mania ratings and a significantly greater proportion of patients achieving protocol-defined remission, compared with the divalproex treatment group. Significantly more weight gain and cases of dry mouth, increased appetite, and somnolence were reported with olanzapine, while more cases of nausea were reported with divalproex.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744 · cited 2×
“A minimum total score of 20 on the Young Mania Rating Scale (7) was required at both the screening visit and on the day of random assignment to study groups (baseline).”
MethodDevelopment of a Rating Scale for Primary Depressive Illness
HAMILTON, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410
A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS
SIMPSON, G. M., B., M., B., G., ANGUS, J. W. S., P., F. R. C., & M., D. P. (1970) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1970.tb02066.x · Cited by 3,264
A Rating Scale for Drug-Induced Akathisia
Barnes, T. R. E. (1989) · British Journal of Psychiatry · doi:10.1192/bjp.154.5.672 · Cited by 2,170
The epidemiology of DSM-III-R bipolar I disorder in a general population survey
KESSLER, R. C., RUBINOW, D. R., HOLMES, C., ABELSON, J. M., & ZHAO, S. (1997) · Psychological Medicine · doi:10.1017/s0033291797005333 · Cited by 600
Olanzapine versus placebo in the treatment of acute mania
Tohen, M., Sanger, T. M., McElroy, S. L., Tollefson, G. D., Chengappa, K. N. R., Daniel, D. G., Petty, F., Centorrino, F., Wang, R., Grundy, S. L., et al. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.702 · Cited by 585
Self-citationTohen, M. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.9.841 · Cited by 539
Self-citationValproatereatment of Acute Mania: A Placebo-Controlled
Pope, H. G. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810250064008 · Cited by 460
The B-Value: A Tool for Monitoring Data
Lan, K. K. G., & Wittes, J. (1988) · Biometrics · doi:10.2307/2531870 · Cited by 303
Relation of serum valproate concentration to response in mania
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.6.765 · Cited by 163
Valproate oral loading in the treatment of acute mania.
Keck, P. E., McElroy, S. L., Tuğrul, K., & Bennett, J. A. (1993) · PubMed · Cited by 138
Safety and Tolerability of Oral Loading Divalproex Sodium in Acutely Manic Bipolar Patients
Hirschfeld, R. M. A., Allen, M. H., McEvoy, J. P., Keck, P. E., & Russell, J. M. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n1202 · Cited by 134
McElroy, S. L., Keck, P. E., Stanton, S. P., Tugrul, K. C., Bennett, J. A., & Strakowski, S. M. (1996) · PubMed · Cited by 133
Epidemiology of Bipolar Disorder
Tohen, M. F., & Angst, J. (2002) · Wiley eBooks · doi:10.1002/0471234311.ch17 · Cited by 75
Self-citationStatistical studies of prognosis in advanced breast cancer
Armitage, P., McPherson, C. K., & Copas, J. C. (1969) · Journal of Chronic Diseases · doi:10.1016/0021-9681(69)90076-9 · Cited by 28
New Perspectives in the Acute Treatment of Bipolar Depression
Grunze, H., Schlösser, S., & Walden, J. (2000) · The World Journal of Biological Psychiatry · doi:10.3109/15622970009150580 · Cited by 9
Efficacy of Divalproex vs Lithium and Placebo in the Treatment of Mania
Bowden, C. L. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510360044034 · Cited by 1
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Self-citationTohen, M., Vieta, E., Calabrese, J., Ketter, T. A., Sachs, G., Bowden, C., Mitchell, P. B., Centorrino, F., Risser, R., Baker, R. W., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.11.1079 · Cited by 908
Self-citationWhat Is a “Mood Stabilizer”? An Evidence-Based Response
Bauer, M. S., & Mitchner, L. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.3 · Cited by 862
Murray, R. M., Sham, P., Van Os, J., Zanelli, J., Cannon, M., & McDonald, C. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.03.002 · Cited by 516
Grunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H.-J., Kasper, S., & on behalf of the WFSBP Task Force on Treatment Guidelines for Bipolar Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.770551 · Cited by 421
Metadata
- Authors
- Tohen, M., Baker, R. W., Altshuler, L. L., Zarate, C. A., Suppes, T., Ketter, T. A., Milton, D. R., Risser, R., Gilmore, J. A., Breier, A., & Tollefson, G. A.
- Venue
- American Journal of Psychiatry
- Published
- 2002-06-01
- Volume
- 159
- Issue
- 6
- Pages
- 1011-1017
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2145776998
- Cited by
- 256
- References
- 17
- FWCI
- 20.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.